Sampann Utpadan [SAMPANN] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison

Sampann Utpadan India Limited

NSE
Loading...

Neogen Chemicals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sampann Utpadan India Limited wins in 10 metrics, Neogen Chemicals Ltd. wins in 9 metrics, with 0 ties. Sampann Utpadan India Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sampann Utpadan India Limited Neogen Chemicals Ltd. Better
P/E Ratio (TTM) 12.89 222.22 Sampann Utpadan India Limited
Price-to-Book Ratio 3.50 5.46 Sampann Utpadan India Limited
Debt-to-Equity Ratio 211.46 141.47 Neogen Chemicals Ltd.
PEG Ratio -0.05 -3.52 Sampann Utpadan India Limited
EV/EBITDA 20.37 42.55 Sampann Utpadan India Limited
Profit Margin (TTM) 8.40% 2.41% Sampann Utpadan India Limited
Operating Margin (TTM) 7.34% 11.39% Neogen Chemicals Ltd.
EBITDA Margin (TTM) 7.34% 11.39% Neogen Chemicals Ltd.
Return on Equity 45.85% 4.41% Sampann Utpadan India Limited
Return on Assets (TTM) 2.76% 1.99% Sampann Utpadan India Limited
Free Cash Flow (TTM) $-69.79M $-1.22B Sampann Utpadan India Limited
Dividend Yield N/A 0.19% N/A
1-Year Return -14.21% 10.59% Neogen Chemicals Ltd.
Price-to-Sales Ratio (TTM) 1.19 5.56 Sampann Utpadan India Limited
Enterprise Value $2.44B $53.55B Neogen Chemicals Ltd.
EV/Revenue Ratio 1.85 6.55 Sampann Utpadan India Limited
Gross Profit Margin (TTM) 20.94% 47.11% Neogen Chemicals Ltd.
Revenue per Share (TTM) $28 $310 Neogen Chemicals Ltd.
Earnings per Share (Diluted) $2.48 $7.47 Neogen Chemicals Ltd.
Beta (Stock Volatility) 0.39 0.22 Neogen Chemicals Ltd.

Sampann Utpadan India Limited vs Neogen Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

SAMPANN
NEOGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sampann Utpadan India Limited0.60%-0.99%-1.61%-3.02%-14.71%-18.05%
Neogen Chemicals Ltd.1.29%6.97%12.71%39.41%74.21%61.67%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sampann Utpadan India Limited-14.21%97.34%261.35%341.98%-19.58%-19.58%
Neogen Chemicals Ltd.10.59%19.04%106.75%609.06%609.06%609.06%

Performance & Financial Health Analysis: Sampann Utpadan India Limited vs Neogen Chemicals Ltd.

MetricSAMPANNNEOGEN
Market Information
Market Cap i₹1.56B₹44.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i52,125170,744
90 Day Avg. Volume i43,290127,390
Last Close₹26.96₹1,901.20
52 Week Range₹23.75 - ₹43.44₹966.70 - ₹1,960.30
% from 52W High-37.94%-3.01%
All-Time High₹63.45 (Jan 10, 2022)₹2,420.00 (Dec 09, 2024)
% from All-Time High-57.51%-21.44%
Growth Metrics
Quarterly Revenue Growth0.53%0.09%
Quarterly Earnings Growth0.60%-0.63%
Financial Health
Profit Margin (TTM) i0.08%0.02%
Operating Margin (TTM) i0.07%0.11%
Return on Equity (TTM) i0.46%0.04%
Debt to Equity (MRQ) i211.46141.47
Cash & Liquidity
Book Value per Share (MRQ)₹9.14₹303.78
Cash per Share (MRQ)₹0.09₹57.58
Operating Cash Flow (TTM) i₹-137,372,200₹645.50M
Levered Free Cash Flow (TTM) i₹39.76M₹348.30M
Dividends
Last 12-Month Dividend Yield iN/A0.19%
Last 12-Month Dividend iN/A₹3.00

Valuation & Enterprise Metrics Analysis: Sampann Utpadan India Limited vs Neogen Chemicals Ltd.

MetricSAMPANN (Apr 24, 2026)NEOGEN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i12.89222.22
Forward P/E iN/A72.26
PEG Ratio i-0.05-3.52
Price to Sales (TTM) i1.195.56
Price to Book (MRQ) i3.505.46
Market Capitalization
Market Capitalization i₹1.56B₹44.76B
Enterprise Value i₹2.44B₹53.55B
Enterprise Value Metrics
Enterprise to Revenue i1.856.55
Enterprise to EBITDA i20.3742.55
Risk & Other Metrics
Beta i0.390.22
Book Value per Share (MRQ) i₹9.14₹303.78

Financial Statements Comparison: Sampann Utpadan India Limited vs Neogen Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSAMPANN (2025)NEOGEN (2025)
Revenue/Sales i926.36M7.58B
Cost of Goods Sold i826.90M4.44B
COGS % of Revenue i89.3%58.6%
Gross Profit i99.47M3.13B
Gross Margin i10.7%41.4%
Research & Development iN/A11.50M
Operating Income (EBIT) i-67.31M1.09B
Operating Margin i-7.3%14.4%
EBITDA i40.69M1.31B
EBITDA Margin i4.4%17.3%
Pre-Tax Income i53.77M501.60M
Pre-Tax Income % of Revenue i5.8%6.6%
Income Tax i14.01M153.30M
Income Tax % of Revenue i1.5%2.0%
Net Income (Profit) i39.76M348.30M
Profit Margin i4.3%4.6%

Balance Sheet & Liquidity Metrics

MetricSAMPANN (2025)NEOGEN (2025)
Cash & Equivalents i4.88M49.60M
Total Current Assets i341.96M10.00B
Total Current Assets % of Revenue i36.9%132.0%
Total Current Liabilities i197.87M7.33B
Total Current Liabilities % of Revenue i21.4%96.8%
Long-Term Debt i843.07M1.94B
Long-Term Debt % of Revenue i91.0%25.6%
Total Shareholders Equity i180.33M7.89B
Retained Earnings i-407.51M2.28B
Retained Earnings % of Revenue i-44.0%30.1%
Property, Plant & Equipment i737.92M890.30M

Cash Flow Statement Comparison

MetricSAMPANN (2025)NEOGEN (2025)
Operating Cash Flow i-137.37M645.50M
Operating Cash Flow % of Revenue i-14.8%8.5%
Capital Expenditures i-72.48M-3.17B
Free Cash Flow i-69.79M-1.22B
FCF Margin i-7.5%-16.1%
Debt Repayment iN/A-718.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMPANNNEOGEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i48.81M27.38M
Float Shares i20.53M13.28M
% Held by Insiders i66.77%53.98%
% Held by Institutions i10.79%23.81%
% Held by Public i22.44%22.21%

Dividend Analysis & Yield Comparison: Sampann Utpadan India Limited vs Neogen Chemicals Ltd.

MetricSAMPANNNEOGEN
Last 12-Month Dividend iN/A₹3.00
Last 12-Month Dividend Yield iN/A0.19%
3-Year Avg Annual Dividend iN/A₹2.00
3-Year Avg Dividend Yield iN/A0.11%
3-Year Total Dividends iN/A₹6.00
Ex-Dividend DateN/ASep 19, 2025